A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer
Clinical trial NCT06791161 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06791161
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-19
- Primary completion
- 2030-01-18
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.